[1]
“IDENTIFYING CONTRIBUTING VARIABLES AND DELAYED ADVERSE RESPONSES IN WHOLE BLOOD DONORS”, Int. Res. J. Pharm., vol. 15, no. 3, pp. 32–37, Mar. 2024, doi: 10.56802/t7q9nw43.